Published :
Tables : 19
Figures : 31
Category : Healthcare
No. of Pages : 250
Report Code : HC-1021
Inhaler Device Packaging Market Introduction Currently, inhalation therapy is the best option for lung diseases like Asthma, COPD etc. This local therapy allows the use of a smaller dose and reduces systemic side effects. The packaging for inhalation devices includes paper and metal made materials. The packaging for inhalation drugs should not alter any properties of the main component and it should be stable throughout the life cycle of the product until it reaches the end user. Inhaler Device Packaging Market Overview Rising demand for packaging material to increase the protection of drug substances led to robust growth of the market. Inhaler device packaging is used to retain the quality and efficiency of the formulation. The packaging material is an integral part of pharmaceutical products and intended to protect the product from the external environment. Containments impact the stability of the drug and can affect the health of patients. Rising concern of contamination led to the potential growth of the market. Further changing regulatory scenarios to prevent the drug contamination led to robust growth of the market. Additionally, the rapid advancement of technologies led to developed of the fully automated process of manufacturing. All these factors led to the potential growth of market. Asia Pacific region created a potential opportunistic space for manufacturers due to a large number of pharmaceutical manufacturers in these regions. They are expected to witness the highest growth rate in global inhaler device packaging market. They account significant share in the global market. It was followed by North America and Europe inhaler device packaging market. Rest of the world is expected to account significant share in global inhaler device packaging market due to increasing adoption. Major Market Players include 3M Health Care, Baxter International, OMRON Healthcare, PARI Medical Holding, Smith Medicals and others. Manufacturers are more focused on organic growth through expansions and collaboration to remain dominant in the global Inhaler Device Packaging market. Inhaler Device Packaging Market Segmentation By Product Vials Ampoules By End-User Contract Manufacturing Organizations Pharmaceutical Companies By Region Europe North America APAC Latin America Rest of World Competitive Landscape: Tier 1 players- established companies in the market with a major market share Tier 2 players Emerging players which are growing rapidly New Entrants FutureWise Takeaways Growth prospects SWOT analysis Key trends Key data-points affecting market growth Objectives of the Study: To provide with an exhaustive analysis on the global inhaler device packaging market on the basis of product, end-use and region To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) To evaluate and forecast micro-markets and an overall market To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America, and the Middle East To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions Profiling of companies to evaluate their market shares, strategies, financials and core competencies
Currently, inhalation therapy is the best option for lung diseases like Asthma, COPD etc. This local therapy allows the use of a smaller dose and reduces systemic side effects. The packaging for inhalation devices includes paper and metal made materials. The packaging for inhalation drugs should not alter any properties of the main component and it should be stable throughout the life cycle of the product until it reaches the end user.
Inhaler Device Packaging Market Overview
Rising demand for packaging material to increase the protection of drug substances led to robust growth of the market. Inhaler device packaging is used to retain the quality and efficiency of the formulation. The packaging material is an integral part of pharmaceutical products and intended to protect the product from the external environment. Containments impact the stability of the drug and can affect the health of patients. Rising concern of contamination led to the potential growth of the market. Further changing regulatory scenarios to prevent the drug contamination led to robust growth of the market. Additionally, the rapid advancement of technologies led to developed of the fully automated process of manufacturing. All these factors led to the potential growth of market.
Asia Pacific region created a potential opportunistic space for manufacturers due to a large number of pharmaceutical manufacturers in these regions. They are expected to witness the highest growth rate in global inhaler device packaging market. They account significant share in the global market. It was followed by North America and Europe inhaler device packaging market. Rest of the world is expected to account significant share in global inhaler device packaging market due to increasing adoption.
Major Market Players include 3M Health Care, Baxter International, OMRON Healthcare, PARI Medical Holding, Smith Medicals and others. Manufacturers are more focused on organic growth through expansions and collaboration to remain dominant in the global Inhaler Device Packaging market.
Inhaler Device Packaging Market Segmentation
By Product
By End-User
By Region
Competitive Landscape:
FutureWise Takeaways
Objectives of the Study:
1. Market Introduction 1.1 Objectives of the Study 1.2 Market Definition 1.3 Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4 Currency 1.5 Limitations 1.6 Stakeholders 2. Research Methodology 2.1 Research Data 2.1.1 Secondary Data 2.1.1.1 Key Data From Secondary Sources 2.1.2 Primary Data 2.1.2.1 Key Data From Primary Sources 2.2 Market Size Estimation 2.3 Market Breakdown and Data Triangulation 2.4 Assumptions for the Study 3. Executive Summary 3.1 Market Outlook 3.2 Segment Outlook 3.3 Competitive Insights 4. Global Inhaler Device Packaging Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards And Compliances 5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Global Inhaler Device Packaging Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. Global Inhaler Device Packaging Market, By Product Historical Analysis and Forecast 2020-2027 (USD Million) 7.1. Vials 7.2. Ampoules 8. Global Inhaler Device Packaging Market, By End User Historical Analysis and Forecast 2020-2027 (USD Million) 8.1. Contract Manufacturing Organizations 8.2. Pharmaceutical Companies 9. North America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) along with expected regulatory needs 9.1. Introduction 9.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 9.2.1. U.S.A 9.2.2. Canada 9.2.3. Mexico 9.3. Market Size (USD Million) Forecast for North America 2020-2027 10. Europe Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 10.1. Introduction 10.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 10.2.1. Germany 10.2.2. U.K 10.2.3. France 10.2.4. Italy 10.2.5. Spain 10.2.6. Russia 10.2.7. Poland 10.2.8. Switzerland 10.2.9. Rest of Western Europe 11. Asia Pacific Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) - along with expected regulatory needs 11.1. Introduction 11.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 11.2.1. Japan 11.2.2. China 11.2.3. Singapore 11.2.4. India 11.2.5. Australia and New Zealand 11.2.6. ASEAN 11.2.7. South Korea 11.2.8. Rest of Asia Pacific 11.3. Market Size (USD Million) Forecast for Asia Pacific 2020-2027 12. Latin America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 12.1. Introduction 12.2. Regional Market Trends 12.3. Historical Market Size (USD Million) Analysis By Country, 2015-2019 12.3.1. Brazil 12.3.2. Venezuela 12.3.3. Argentina 12.3.4. Rest of Latin America 12.4. Market Size (USD Million) Forecast for Latin America 2020-2027 13. Rest of the World Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) along with expected regulatory needs 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 13.2.1. Saudi Arabia 13.2.2. UAE 13.2.3. South Africa 13.2.4. Egypt 13.3. Market Size (USD Million) Forecast for MEA 2020-2027 14. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Type and Technology Portfolio, Financial Layouts) 14.1. 3M Health Care 14.1.1. Company Overview 14.1.2. Product Portfolio 14.1.3. SWOT Analysis 14.1.4. Financial Overview 14.1.5. Strategic Overview 14.2. Baxter International 14.2.1. Company Overview 14.2.2. Product Portfolio 14.2.3. SWOT Analysis 14.2.4. Financial Overview 14.2.5. Strategic Overview 14.3. OMRON Healthcare 14.3.1. Company Overview 14.3.2. Product Portfolio 14.3.3. SWOT Analysis 14.3.4. Financial Overview 14.3.5. Strategic Overview 14.4. PARI Medical Holding 14.4.1. Company Overview 14.4.2. Product Portfolio 14.4.3. SWOT Analysis 14.4.4. Financial Overview 14.4.5. Strategic Overview 14.5. Smith Medicals 14.5.1. Company Overview 14.5.2. Product Portfolio 14.5.3. SWOT Analysis 14.5.4. Financial Overview 14.5.5. Strategic Overview 15. FutureWise SME key takeaway points for Client
1. Market Introduction 1.1 Objectives of the Study 1.2 Market Definition 1.3 Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4 Currency 1.5 Limitations 1.6 Stakeholders 2. Research Methodology 2.1 Research Data 2.1.1 Secondary Data 2.1.1.1 Key Data From Secondary Sources 2.1.2 Primary Data 2.1.2.1 Key Data From Primary Sources 2.2 Market Size Estimation 2.3 Market Breakdown and Data Triangulation 2.4 Assumptions for the Study 3. Executive Summary 3.1 Market Outlook 3.2 Segment Outlook 3.3 Competitive Insights 4. Global Inhaler Device Packaging Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards And Compliances 5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Global Inhaler Device Packaging Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. Global Inhaler Device Packaging Market, By Product Historical Analysis and Forecast 2020-2027 (USD Million) 7.1. Vials 7.2. Ampoules 8. Global Inhaler Device Packaging Market, By End User Historical Analysis and Forecast 2020-2027 (USD Million) 8.1. Contract Manufacturing Organizations 8.2. Pharmaceutical Companies 9. North America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) along with expected regulatory needs 9.1. Introduction 9.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
9.2.1. U.S.A 9.2.2. Canada 9.2.3. Mexico
9.3. Market Size (USD Million) Forecast for North America 2020-2027 10. Europe Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 10.1. Introduction 10.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
10.2.1. Germany 10.2.2. U.K 10.2.3. France 10.2.4. Italy 10.2.5. Spain 10.2.6. Russia 10.2.7. Poland 10.2.8. Switzerland 10.2.9. Rest of Western Europe
11. Asia Pacific Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) - along with expected regulatory needs 11.1. Introduction 11.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
11.2.1. Japan 11.2.2. China 11.2.3. Singapore 11.2.4. India 11.2.5. Australia and New Zealand 11.2.6. ASEAN 11.2.7. South Korea 11.2.8. Rest of Asia Pacific
11.3. Market Size (USD Million) Forecast for Asia Pacific 2020-2027 12. Latin America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 12.1. Introduction 12.2. Regional Market Trends 12.3. Historical Market Size (USD Million) Analysis By Country, 2015-2019
12.3.1. Brazil 12.3.2. Venezuela 12.3.3. Argentina 12.3.4. Rest of Latin America
12.4. Market Size (USD Million) Forecast for Latin America 2020-2027 13. Rest of the World Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) along with expected regulatory needs 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
13.2.1. Saudi Arabia 13.2.2. UAE 13.2.3. South Africa 13.2.4. Egypt
13.3. Market Size (USD Million) Forecast for MEA 2020-2027
14. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Type and Technology Portfolio, Financial Layouts) 14.1. 3M Health Care 14.1.1. Company Overview 14.1.2. Product Portfolio 14.1.3. SWOT Analysis 14.1.4. Financial Overview 14.1.5. Strategic Overview 14.2. Baxter International 14.2.1. Company Overview 14.2.2. Product Portfolio 14.2.3. SWOT Analysis 14.2.4. Financial Overview 14.2.5. Strategic Overview 14.3. OMRON Healthcare 14.3.1. Company Overview 14.3.2. Product Portfolio 14.3.3. SWOT Analysis 14.3.4. Financial Overview 14.3.5. Strategic Overview 14.4. PARI Medical Holding 14.4.1. Company Overview 14.4.2. Product Portfolio 14.4.3. SWOT Analysis 14.4.4. Financial Overview 14.4.5. Strategic Overview 14.5. Smith Medicals 14.5.1. Company Overview 14.5.2. Product Portfolio 14.5.3. SWOT Analysis 14.5.4. Financial Overview 14.5.5. Strategic Overview 15. FutureWise SME key takeaway points for Client
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics